In contrast, circulating MAGE-A-specific CD8+ T cells obtained from HCC patients largely consisted of antigen-experienced cells, however, with a high inter-individual variability (HCC: Median: 52.9%; IQR: 60.8%). Here, CD8A is linked to hepatocellular carcinoma.